Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Auragent Bioscience LLC
- Proposal award date
- 2022-09-17
- Contract end date
- 2024-08-31
- UEI
- FGXDBY8YCNK1
- Solicitation number
- PA21-259
- Topic code
- 400
Research abstract
AbstractSecretory proteins are fundamental to local and systemic cellular signaling in biological systems.
The regulation and dysregulation of the networks involving these proteins plays a critical role in
health, aging, and development of disease. As such, study of these proteins and their networks
is critical to our understanding of biology. Not surprisingly, this particular set of proteins constitutes
a large proportion of the targets of pharmaceutical drugs, and also represents attractive targets
for diagnostics and future precision medicine efforts. Unfortunately, many of these secreted
proteins are difficult to detect. There are existing technologies for studying these secreted proteins
but they either underperform, are extremely expensive and/or complex given their specific-utility.
containing multiple cell types. Although the need to study secreted proteins is ubiquitous, there
is not a technology that is widely available (inexpensive) and capable of providing
information on multiple secreted proteins simultaneously at single-cell resolution, and we
aim to address this need in the current project.At the core of our technologies is the Plasmonic Fluor (PF), our proprietary, ultrabright
fluorescent nanoconstruct designed to enhance the performance of fluorescence-based
immunoassays. We have already built a high-sensitivity, multiplexed immunoassay platform
leveraging this technology, which is currently being tested with external collaborators. This
platform includes an inexpensive, high performance, single-laser fluorescence microplate/slide
reader optimized for use with our PFs. We will extend this existing platform to accommodate PF-
enhanced cellular secretion assays we call PFluorospot. The upgraded platform that will result
from the proposed effort will be a truly versatile and powerful tool for the measurement of
proteins.In our preliminary work, we have successfully manufactured at commercial scale and with high
reproducibility streptavidin-conjugated PFs that are spectrally equivalent to FITC, Cy3, and Cy5
(PF490, PF550, and PF650, respectively). We have also created three PFs with entirely unique
excitation/emission spectra: two which have excitation spectra like FITC and emit like Cy3 and
Cy5 (PF490_550 and PF490_650, respectively), and one which has an excitation spectrum like Cy3 but
emits like Cy5 (PF550_650). These unique PFs were synthesized at a prototype scale which we aim
to scale up in this effort because they will allow 3 lasers to be used to interrogate 6 separate
targets. In a demonstration of applicability to cellular secretion assays, streptavidin-PF550 and
PF650 were conjugated to antibodies at a small scale and used to perform dual-color PFluorospot.
These initial PFluorospot experiments show that additional information can be obtained in these
assays relative to ELISPOT/FluoroSpot, and are simpler and significantly faster to perform. It was
possible to visualize individual cells for adherent cells and better localize secreting cells. This is
particularly important for understanding heterogeneity, spatial effects in co-culture, and
polyfunctionality, and we propose to add a 4th laser to our reader to accommodate cell markers.
Additionally, a single-color PFluorospot assay was read with our existing reader and
demonstrated high sensitivity, high resolution, and short read times.We believe our Pfluorospot platform and reader will become the go-to secretomics platform, and
will empower many more biological researchers to measure important, secreted proteins.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
5 SBIR/STTR records share this UEI (2019–2024). Reported award amounts total $5,779,375. Reported amounts are not federal obligations.
Phases: Phase II – Direct to Phase II, Phase I, Phase II
Agencies: Department of Health and Human Services
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards